161 related articles for article (PubMed ID: 37264386)
1. Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis.
Ma Y; Li J; Wen L; Zhang G; Yao X
World J Surg Oncol; 2023 Jun; 21(1):165. PubMed ID: 37264386
[TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis of Efficacy and Safety of Karelizumab Combined with Apatinib in the Treatment of Advanced Gastric Cancer.
Liu H; Li Y; Yao Y; Chen K; Gan J
Dis Markers; 2022; 2022():6971717. PubMed ID: 36193493
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of safety and efficacy of apatinib combination with chemotherapy for ovarian cancer treatment: a systematic review and meta-analysis.
Qi J; Liu E; Yue H; Chen G; Liu Y; Chen J
Ann Palliat Med; 2021 Sep; 10(9):9902-9913. PubMed ID: 34551570
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of apatinib combined with chemotherapy for the treatment of advanced gastric cancer in the Chinese population: a systematic review and meta-analysis.
Cheng H; Sun A; Guo Q; Zhang Y
Drug Des Devel Ther; 2018; 12():2173-2183. PubMed ID: 30034222
[TBL] [Abstract][Full Text] [Related]
5. Apatinib combined with chemotherapy or concurrent chemo-brachytherapy in patients with recurrent or advanced cervical cancer: A phase 2, randomized controlled, prospective study.
Guo Q; Sun Y; Kong E; Rao L; Chen J; Wu Q; Zhang T; Liu N; Li M; Sun L
Medicine (Baltimore); 2020 Mar; 99(11):e19372. PubMed ID: 32176061
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of apatinib monotherapy for patients with advanced breast cancer: a systematic review and meta-analysis.
Huang X; Hu X; Yi T
Front Oncol; 2022; 12():940171. PubMed ID: 35978823
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis.
Gong A; Li X
World J Surg Oncol; 2022 Mar; 20(1):69. PubMed ID: 35246145
[TBL] [Abstract][Full Text] [Related]
8. What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis.
Hui F; Xu C; Xu X; Chen J; Geng H; Yang C; Zhang Y
Front Oncol; 2022; 12():887332. PubMed ID: 35692745
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. The combination of apatinib and S-1 for the treatment of advanced gastric cancer in China: A meta-analysis of randomized controlled trials.
Liu Y; Zhou C; Zhang K; Feng Y; Zhang R
Medicine (Baltimore); 2018 Nov; 97(47):e13259. PubMed ID: 30461630
[TBL] [Abstract][Full Text] [Related]
11. Xiaoaiping injection combined with chemotherapy for advanced gastric cancer: An updated systematic review and meta-analysis.
Zhou XQ; Chang YZ; Shen CY; Han J; Chang RA
Front Pharmacol; 2022; 13():1023314. PubMed ID: 36249747
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of apatinib in patients with advanced nonsmall cell lung cancer that failed prior chemotherapy or EGFR-TKIs: A pooled analysis.
Ma JT; Sun J; Sun L; Zhang SL; Huang LT; Han CB
Medicine (Baltimore); 2018 Aug; 97(35):e12083. PubMed ID: 30170427
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of targeted therapeutics for patients with radioiodine-refractory differentiated thyroid cancer: Systematic review and network meta-analysis.
Ji X; Liang W; Lv G; Ding C; Lai H; Li L; Zeng Q; Lv B; Sheng L
Front Pharmacol; 2022; 13():933648. PubMed ID: 36091770
[No Abstract] [Full Text] [Related]
14. A comparison of transcatheter arterial chemoembolization used with and without apatinib for intermediate- to advanced-stage hepatocellular carcinoma: a systematic review and meta-analysis.
Zhao S; Zhang T; Dou W; Wang E; Wang M; Wang C; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):542. PubMed ID: 32411765
[TBL] [Abstract][Full Text] [Related]
15. Modified xiaoyao san combined with chemotherapy for breast cancer: A systematic review and meta-analysis of randomized controlled trials.
Pan J; Fu S; Zhou Q; Lin D; Chen Q
Front Oncol; 2023; 13():1050337. PubMed ID: 37035186
[TBL] [Abstract][Full Text] [Related]
16. Acupuncture treatment vs. cognitive rehabilitation for post-stroke cognitive impairment: A systematic review and meta-analysis of randomized controlled trials.
Liu Y; Chen F; Qin P; Zhao L; Li X; Han J; Ke Z; Zhu H; Wu B
Front Neurol; 2023; 14():1035125. PubMed ID: 36846126
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non-small cell lung cancer: A meta-analysis.
Li Z; Liu Z; Wu Y; Li H; Sun Z; Han C; Zhang X; Zhang J
Thorac Cancer; 2021 Nov; 12(21):2838-2848. PubMed ID: 34622571
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis.
Peng D; Cai Y; Chen G; Hou M; Luo X; Dongzhi Z; Xie H; Liu Y
Front Pharmacol; 2023; 14():1101063. PubMed ID: 37153777
[No Abstract] [Full Text] [Related]
19. Comparison of the efficacy and safety of third-line treatments for advanced gastric cancer: A systematic review and network meta-analysis.
Zhang C; Xiang Y; Wang J; Yan D
Front Oncol; 2023; 13():1118820. PubMed ID: 36937403
[TBL] [Abstract][Full Text] [Related]
20. Chinese Herbal Medicine for Functional Dyspepsia With Psychological Disorders: A Systematic Review and Meta-Analysis.
Luo X; Wang L; Fang S; Qing X; Jiang T; Yang Y; Su X; Wei W
Front Neurosci; 2022; 16():933290. PubMed ID: 35911981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
